Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 82804-296

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 82804-296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

Bupropion-structure.jpg (Bupropion Structure)
Chemical structure of bupropion hydrochloride, showing its substituted phenyl ring with chlorine and the tert-butyl group attached to the carbonyl and amine functional groups, including the hydrochloride component.*
FDA Label Image

82804-296-90 (Image 01)

82804-296-90 (Image 01)
Label for Bupropion HCl 150 mg extended-release tablets by Proficient Rx LP. The label states "Once-Daily" dosage, includes medication guide instructions, warning against use with Zytan or other bupropion products, and storage at 25°C. Manufactured by Granules India Limited in Hyderabad, India. Contains NDC 82804-296-90 and product ID ZB029690.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.